UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 272

Sortiert nach

The AMPK stress response pathway mediates anoikis resistance through inhibition of mTOR and suppression of protein synthesis

Cell death and differentiation, 2012-03, Vol.19 (3), p.501-510

2012

Link zum Volltext

Verfügbarkeit prüfen

Transcriptional profiling of primary prostate tumor in metastatic hormone-sensitive prostate cancer and association with clinical outcomes: correlative analysis of the E3805 CHAARTED trial

Annals of oncology, 2021-09, Vol.32 (9), p.1157-1166

2021

Link zum Volltext

Verfügbarkeit prüfen

Validation of the Decipher genomic classifier in patients receiving salvage radiotherapy without hormone therapy after radical prostatectomy – an ancillary study of the SAKK 09/10 randomized clinical trial

Annals of oncology, 2022-09, Vol.33 (9), p.950-958

2022

Link zum Volltext

Verfügbarkeit prüfen

Correlation of B7-H3 with androgen receptor, immune pathways and poor outcome in prostate cancer: an expression-based analysis

Prostate cancer and prostatic diseases, 2017-03, Vol.20 (1), p.28-35

2017

Link zum Volltext

Verfügbarkeit prüfen

Cell cycle-coupled expansion of AR activity promotes cancer progression

Oncogene, 2017-03, Vol.36 (12), p.1655-1668

2017

Link zum Volltext

Verfügbarkeit prüfen

Utilization of biopsy-based genomic classifier to predict distant metastasis after definitive radiation and short-course ADT for intermediate and high-risk prostate cancer

Prostate cancer and prostatic diseases, 2017-06, Vol.20 (2), p.186-192

2017

Link zum Volltext

Verfügbarkeit prüfen

A genomic classifier predicting metastatic disease progression in men with biochemical recurrence after prostatectomy

Prostate cancer and prostatic diseases, 2014-03, Vol.17 (1), p.64-69

2014

Link zum Volltext

Verfügbarkeit prüfen

Decipher correlation patterns post prostatectomy: initial experience from 2 342 prospective patients

Prostate cancer and prostatic diseases, 2016-12, Vol.19 (4), p.374-379

2016

Link zum Volltext

Verfügbarkeit prüfen

The Frequency of Druggable Targets in Localized Prostate Cancer: Initial Analysis From a Commercially Available Genomic Expression Database in Urologic Cancer

International journal of radiation oncology, biology, physics, 2016-10, Vol.96 (2), p.E251-E252

2016

Link zum Volltext

Verfügbarkeit prüfen

The Use of a Biopsy-Based Genomic Classifier to Predict the Risk of Distant Metastasis After Definitive Radiation and Short-Course Androgen Deprivation Therapy for Intermediate- and High-Risk Prostate Cancer

International journal of radiation oncology, biology, physics, 2016-10, Vol.96 (2), p.S113-S114

2016

Link zum Volltext

Verfügbarkeit prüfen

Efficacy of Postoperative Radiation in a Prostatectomy Cohort Adjusted for Clinical and Genomic Risk

International journal of radiation oncology, biology, physics, 2016-10, Vol.96 (2), p.S103-S104

2016

Link zum Volltext

Verfügbarkeit prüfen

A Genomic Classifier Impacts Treatment Decision Making Among Patients With Biochemical Recurrence After Radical Prostatectomy: Results From the Multicenter Prospective PRO-IMPACT Study

International journal of radiation oncology, biology, physics, 2016-10, Vol.96 (2), p.E222-E223

2016

Link zum Volltext

Verfügbarkeit prüfen

Development and Validation of Genomic Signature That Predicts Androgen Deprivation Therapy Treatment Failure

International journal of radiation oncology, biology, physics, 2016-10, Vol.96 (2), p.E221-E221

2016

Link zum Volltext

Verfügbarkeit prüfen

Identification and Validation of Intrinsic Subtypes of Prostate Cancer

International journal of radiation oncology, biology, physics, 2016-10, Vol.96 (2), p.S3-S4

2016

Link zum Volltext

Verfügbarkeit prüfen

A 24-Gene Predictor of Response to Postoperative Radiation Therapy in Prostate Cancer

International journal of radiation oncology, biology, physics, 2016-10, Vol.96 (2), p.S104-S105

2016

Link zum Volltext

Verfügbarkeit prüfen

Validation of a Genomic Classifier for Prediction of Metastasis Following Postoperative Salvage Radiation Therapy

International journal of radiation oncology, biology, physics, 2015-11, Vol.93 (3), p.S134-S134

2015

Link zum Volltext

Verfügbarkeit prüfen

Efficacy of post-operative radiation in a prostatectomy cohort adjusted for clinical and genomic risk

Prostate cancer and prostatic diseases, 2016-09, Vol.19 (3), p.277-282

2016

Link zum Volltext

Verfügbarkeit prüfen

Using Radiogenomics to Characterize MRI-Guided Prostate Cancer Biopsy Habitats

International journal of radiation oncology, biology, physics, 2015-11, Vol.93 (3), p.E235-E235

2015

Link zum Volltext

Verfügbarkeit prüfen

Patient-Level DNA Damage and Repair Pathway Profiles Are Prognostic After Prostatectomy for High-Risk Prostate Cancer

International journal of radiation oncology, biology, physics, 2015-11, Vol.93 (3), p.S134-S135

2015

Link zum Volltext

Verfügbarkeit prüfen

A Biomarker Panel Associated With Distant Metastasis (DM) in Prostate Cancer Patients Treated With Radiation Therapy Is Also Prognostic for DM in a Large Cohort of Prostatectomy Patients

International journal of radiation oncology, biology, physics, 2015-11, Vol.93 (3), p.E217-E218

2015

Link zum Volltext

Verfügbarkeit prüfen

A Molecular Signature of Radiosensitivity (RSI) is an RT-specific Biomarker in Prostate Cancer

International journal of radiation oncology, biology, physics, 2014-09, Vol.90 (1), p.S157-S157

2014

Link zum Volltext

Verfügbarkeit prüfen

Reconsidering Adjuvant Versus Salvage Radiation Therapy for Prostate Cancer Using an Individualized Decision Analysis With Genomic Classifier Scores

International journal of radiation oncology, biology, physics, 2014-09, Vol.90 (1), p.S585-S585

2014

Link zum Volltext

Verfügbarkeit prüfen

A Genomic Classifier Impacts Adjuvant Treatment Decision Making Among Patients With High-Risk Pathology at Radical Prostatectomy: Results From the Multicenter Prospective PRO-IMPACT Study

International journal of radiation oncology, biology, physics, 2016-10, Vol.96 (2), p.S104-S104

2016

Link zum Volltext

Verfügbarkeit prüfen

High-Throughput Transcriptomic Analysis Nominates Proteasomal Genes As Age Specific Biomarkers and Therapeutic Targets in Prostate Cancer

International journal of radiation oncology, biology, physics, 2015-11, Vol.93 (3), p.S143-S143

2015

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 272

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(231)
Mit Volltextzugriff
(240)

Publikationsform

Artikel
(272)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(100)
Life Sciences & Biomedicine
(94)
Humans
(86)
Male
(83)
Oncology
(62)
Prostatic Neoplasms - Genetics
(62)
Prostate Cancer
(51)
Prostatic Neoplasms - Pathology
(47)
Prognosis
(43)
Urology & Nephrology
(41)
Middle Aged
(40)
Aged
(39)
Urology
(36)
Prostatectomy
(32)
Genomics
(27)
Prostatic Neoplasms - Surgery
(25)
Hematology, Oncology And Palliative Medicine
(24)
Metastasis
(23)
Gene Expression
(22)
Metastases
(22)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(6)
... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

The AMPK stress response pathway mediates anoikis resistance through inhibition of mTOR and suppression of protein synthesis

Transcriptional profiling of primary prostate tumor in metastatic hormone-sensitive prostate cancer and association with clinical outcomes: correlative analysis of the E3805 CHAARTED trial

Validation of the Decipher genomic classifier in patients receiving salvage radiotherapy without hormone therapy after radical prostatectomy – an ancillary study of the SAKK 09/10 randomized clinical trial

Correlation of B7-H3 with androgen receptor, immune pathways and poor outcome in prostate cancer: an expression-based analysis

Neuropilin-1 is upregulated in the adaptive response of prostate tumors to androgen-targeted therapies and is prognostic of metastatic progression and patient mortality

Cell cycle-coupled expansion of AR activity promotes cancer progression

Utilization of biopsy-based genomic classifier to predict distant metastasis after definitive radiation and short-course ADT for intermediate and high-risk prostate cancer

A genomic classifier predicting metastatic disease progression in men with biochemical recurrence after prostatectomy

Decipher correlation patterns post prostatectomy: initial experience from 2 342 prospective patients

The Frequency of Druggable Targets in Localized Prostate Cancer: Initial Analysis From a Commercially Available Genomic Expression Database in Urologic Cancer

The Use of a Biopsy-Based Genomic Classifier to Predict the Risk of Distant Metastasis After Definitive Radiation and Short-Course Androgen Deprivation Therapy for Intermediate- and High-Risk Prostate Cancer

Efficacy of Postoperative Radiation in a Prostatectomy Cohort Adjusted for Clinical and Genomic Risk

A Genomic Classifier Impacts Treatment Decision Making Among Patients With Biochemical Recurrence After Radical Prostatectomy: Results From the Multicenter Prospective PRO-IMPACT Study

Development and Validation of Genomic Signature That Predicts Androgen Deprivation Therapy Treatment Failure

Identification and Validation of Intrinsic Subtypes of Prostate Cancer

A 24-Gene Predictor of Response to Postoperative Radiation Therapy in Prostate Cancer

Validation of a Genomic Classifier for Prediction of Metastasis Following Postoperative Salvage Radiation Therapy

Efficacy of post-operative radiation in a prostatectomy cohort adjusted for clinical and genomic risk

Using Radiogenomics to Characterize MRI-Guided Prostate Cancer Biopsy Habitats

Patient-Level DNA Damage and Repair Pathway Profiles Are Prognostic After Prostatectomy for High-Risk Prostate Cancer

A Biomarker Panel Associated With Distant Metastasis (DM) in Prostate Cancer Patients Treated With Radiation Therapy Is Also Prognostic for DM in a Large Cohort of Prostatectomy Patients

A Molecular Signature of Radiosensitivity (RSI) is an RT-specific Biomarker in Prostate Cancer

Reconsidering Adjuvant Versus Salvage Radiation Therapy for Prostate Cancer Using an Individualized Decision Analysis With Genomic Classifier Scores

A Genomic Classifier Impacts Adjuvant Treatment Decision Making Among Patients With High-Risk Pathology at Radical Prostatectomy: Results From the Multicenter Prospective PRO-IMPACT Study

High-Throughput Transcriptomic Analysis Nominates Proteasomal Genes As Age Specific Biomarkers and Therapeutic Targets in Prostate Cancer

Suchergebnisse filtern